[流感疫苗生产的若干问题]
[Selected problems of manufacturing influenza vaccines].
作者信息
Augustynowicz Ewa
机构信息
Zakład Badania Surowic i Szczepionek, Narodowego Instytutu Zdrowia Publicznego- Państwowego Zakładu Higieny w Warszawie.
出版信息
Przegl Epidemiol. 2010;64(3):373-80.
PMID:20976949
Abstract
In the study chosen issues of manufacturing influenza vaccines running to increase effectiveness were performed. New concepts into development of process of safety and efficacy influenza vaccines are connected with use a new adjuvants, use of alternative routes of administration of vaccine, new structural virus subunits including DNA, new way of virus culture and use of live, attenuated vaccines.
摘要
在所选择的研究中，开展了旨在提高效力的流感疫苗生产相关问题的研究。流感疫苗安全性和有效性研发过程中的新概念与新型佐剂的使用、疫苗给药途径的改变、包括DNA在内的新型病毒结构亚单位、病毒培养的新方法以及减毒活疫苗的使用有关。
相似文献
1
[Selected problems of manufacturing influenza vaccines].[流感疫苗生产的若干问题]
Przegl Epidemiol. 2010;64(3):373-80.
2
Vaccine decisions loom for new flu strain.针对新型流感毒株的疫苗接种决策迫在眉睫。
Nature. 2009 May 14;459(7244):144-5. doi: 10.1038/459144a.
3
Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.比较鸡蛋和高产 MDCK 细胞来源的减毒活流感病毒在商业化生产三价流感疫苗中的应用：在允许和半允许细胞中细胞易感性和流感病毒复制动力学的比较。
Vaccine. 2010 May 14;28(22):3848-55. doi: 10.1016/j.vaccine.2010.03.005. Epub 2010 Mar 20.
4
Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.减毒活流感疫苗中2009 H1N1成分的有效性可能降低。
Clin Infect Dis. 2011 Jul 15;53(2):207-8. doi: 10.1093/cid/cir282.
5
Use of MDCK cells for production of live attenuated influenza vaccine.利用犬肾传代细胞（MDCK细胞）生产减毒活流感疫苗。
Vaccine. 2009 Oct 30;27(46):6460-3. doi: 10.1016/j.vaccine.2009.06.024. Epub 2009 Jun 24.
6
Influenza vaccines: the good, the bad, and the eggs.流感疫苗：优劣与鸡蛋。
Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X.
7
Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.2009年甲型H1N1流感单价疫苗的安全性——美国，2009年10月1日至11月24日
MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6.
8
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.三价减毒活疫苗冷适应流感疫苗与三价灭活流感病毒疫苗在哮喘儿童和青少年中的疗效和安全性比较。
Pediatr Infect Dis J. 2006 Oct;25(10):860-9. doi: 10.1097/01.inf.0000237797.14283.cf.
9
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.在患有反复呼吸道感染的幼儿中，减毒活流感疫苗比灭活流感疫苗具有更高的相对效力。
Pediatr Infect Dis J. 2006 Oct;25(10):870-9. doi: 10.1097/01.inf.0000237829.66310.85.
10
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.Vero 细胞培养衍生流感疫苗：疫苗生产的新视野。
Expert Rev Vaccines. 2012 May;11(5):587-94. doi: 10.1586/erv.12.24.
Zotero 插件